SEC Form D · filed June 30, 2020
Adamis Pharmaceuticals Corp
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (24)
Howard C. Birndorf · San Diego, CADirectorRoshawn C. Blunt · SAN DIEGO, CADirectorDavid J. Marguglio · San Diego, CAExec · DirectorKaren K. Daniels · SAN DIEGO, CAExecRobert O. Hopkins · SAN DIEGO, CAExecRonald B. Moss · San Diego, CAExecRichard C. Williams · San Diego, CADirectorDennis J. Carlo · SAN DIEGO, CAExec · DirectorCharles B. Chippero · ROSWELL, GADirectorIsaiah Gresham · Tacoma, WAExecCarl Gordon · San Diego, CAExec · DirectorDavid Choi · Laurel, MDExecMichael B. Dickens · PITTSBURGH, PAExec · DirectorAlan B. Laing · PHOENIX, AZExecYi Liu · San Diego, CADirectorLynn Yang · San Diego, CADirectorDerek P. Hodges · Huntingtown, MDDirectorZamyra E. Cammans · Luxembourg, LuxembourgExecJosh E. Glaser · New York, NYExecAdam E. Graev · New York, NYExecAlan E. Turner · George Town, Grand Cayman, Cayman IslandsExec · DirectorJoseph P. Simpson · Owings, MDDirectorBlake P. Conner · Miami, FLDirectorHam K. Serunjogi · San Francisco, CAExec · Director Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗